Our results show that UBE2C is highly expressed in ESCC samples, but not in normal mucosa, and that its abrogation is capable of altering proliferation and cell cycle profile of ESCC cell lines, by directly interfering with cyclin B1 protein levels. Here, UBE2C is linked to esophageal squamous cell carcinoma.